Vinter JG - Search Results

1

Rationalizing the activities of diverse cholecystokinin 2 receptor antagonists using molecular field points.

Low CM, Vinter JG. Low CM, et al. Among authors: vinter jg. J Med Chem. 2008 Feb 14;51(3):565-73. doi: 10.1021/jm070880t. Epub 2008 Jan 18. J Med Chem. 2008. PMID: 18201065

2

The design, synthesis and pharmacological characterization of novel β₂-adrenoceptor antagonists.

Hothersall JD, Black J, Caddick S, Vinter JG, Tinker A, Baker JR. Hothersall JD, et al. Among authors: vinter jg. Br J Pharmacol. 2011 Sep;164(2):317-31. doi: 10.1111/j.1476-5381.2011.01269.x. Br J Pharmacol. 2011. PMID: 21323900 Free PMC article.

3

Substituent effects on aromatic stacking interactions.

Cockroft SL, Perkins J, Zonta C, Adams H, Spey SE, Low CM, Vinter JG, Lawson KR, Urch CJ, Hunter CA. Cockroft SL, et al. Among authors: vinter jg. Org Biomol Chem. 2007 Apr 7;5(7):1062-80. doi: 10.1039/b617576g. Epub 2007 Mar 7. Org Biomol Chem. 2007. PMID: 17377660

4

Scaffold hopping with molecular field points: identification of a cholecystokinin-2 (CCK2) receptor pharmacophore and its use in the design of a prototypical series of pyrrole- and imidazole-based CCK2 antagonists.

Low CM, Buck IM, Cooke T, Cushnir JR, Kalindjian SB, Kotecha A, Pether MJ, Shankley NP, Vinter JG, Wright L. Low CM, et al. Among authors: vinter jg. J Med Chem. 2005 Nov 3;48(22):6790-802. doi: 10.1021/jm049069y. J Med Chem. 2005. PMID: 16250638

5

Non-peptide cholecystokinin-B/gastrin receptor antagonists based on bicyclic, heteroaromatic skeletons.

Kalindjian SB, Buck IM, Davies JM, Dunstone DJ, Hudson ML, Low CM, McDonald IM, Pether MJ, Steel KI, Tozer MJ, Vinter JG. Kalindjian SB, et al. Among authors: vinter jg. J Med Chem. 1996 Apr 26;39(9):1806-15. doi: 10.1021/jm9508907. J Med Chem. 1996. PMID: 8627604

6

2,7-Dioxo-2,3,4,5,6,7-hexahydro-1H-benzo[h][1,4]diazonine as a new template for the design of CCK(2) receptor antagonists.

McDonald IM, Dunstone DJ, Kalindjian SB, Linney ID, Low CM, Pether MJ, Steel KI, Tozer MJ, Vinter JG. McDonald IM, et al. Among authors: vinter jg. J Med Chem. 2000 Sep 21;43(19):3518-29. doi: 10.1021/jm000960w. J Med Chem. 2000. PMID: 11000006

7

The matching of electrostatic extrema: a useful method in drug design? A study of phosphodiesterase III inhibitors.

Apaya RP, Lucchese B, Price SL, Vinter JG. Apaya RP, et al. Among authors: vinter jg. J Comput Aided Mol Des. 1995 Feb;9(1):33-43. doi: 10.1007/BF00117276. J Comput Aided Mol Des. 1995. PMID: 7751868

8

Molecular recognition probes of solvation thermodynamics in solvent mixtures.

Amenta V, Cook JL, Hunter CA, Low CM, Vinter JG. Amenta V, et al. Among authors: vinter jg. Org Biomol Chem. 2011 Nov 7;9(21):7571-8. doi: 10.1039/c1ob06083j. Epub 2011 Sep 23. Org Biomol Chem. 2011. PMID: 21946931

9

Influence of solvent polarity on preferential solvation of molecular recognition probes in solvent mixtures.

Amenta V, Cook JL, Hunter CA, Low CM, Vinter JG. Amenta V, et al. Among authors: vinter jg. J Phys Chem B. 2012 Dec 13;116(49):14433-40. doi: 10.1021/jp310379h. Epub 2012 Nov 28. J Phys Chem B. 2012. PMID: 23190174

10

Quantification of functional group interactions in transition states.

Hunter CA, Low CM, Vinter JG, Zonta C. Hunter CA, et al. Among authors: vinter jg. J Am Chem Soc. 2003 Aug 20;125(33):9936-7. doi: 10.1021/ja034767d. J Am Chem Soc. 2003. PMID: 12914452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results